Cambridge Enterprise is thrilled to announce a monumental funding achievement, as Cambridge-founded tech companies have collectively raised £2.2 billion to support breakthrough innovations that bridge academic research and market impact. As the commercialisation arm of the University of Cambridge, Cambridge Enterprise has long been at the forefront of nurturing brilliant ideas and transforming them into real-world solutions. This recent influx of capital underscores not only the global confidence in our unique model—the translation of pioneering research into products, services, and technologies—but also the vital role we play in catalyzing advancements in various sectors. From revolutionary stem cell research and life-changing medical technologies to critical innovations like suspension systems for Formula 1 racing and environmentally sustainable solutions that support biodiversity, this funding empowers our university partners to reach new heights. The funds will be strategically deployed across academic consultancy, intellectual property management, venture building, venture funding, and initiatives that connect and convene the wider Cambridge innovation ecosystem. Our mission is to ensure that every seed of innovation sown at the University of Cambridge blossoms into a lasting contribution to society, creating benefits not only for the University and the UK at large but for the world. As we celebrate this financial milestone, Cambridge Enterprise reaffirms its commitment to making a positive impact and shaping a legacy of transformative breakthroughs. This funding injects fresh momentum into our ever-evolving journey, laying a robust foundation for emerging technologies and visionary ideas destined to change the world.
Cambridge Enterprise Drives Global Impact as Cambridge-founded Tech Companies Secure $2.2 Billion in Funding
Get the full Cambridge-founded tech companies company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dangote Industries Limited
Driving Africa’s economic growth through industrial excellence and empowering lives.
$600.0M Unknown
today
Prime Meridian Docks Ghana
Prime Meridian Docks Ghana Limited is West Africa’s newest repair and maintenance facility, catering for the needs of the maritime transportation, fishing and offshore oil and gas industries.
$137.0M Unknown
today
Arrw By RehlaRides
ARRW Egypt’s first ride-hailing licensed app, built to deliver reliability, comfort & affordability. Now in Alexandria ARRW سكة جديدة
$4.0M Seed
today
Undo
Undo provides the runtime context that makes coding agents work on the most complex codebases. AI performance = model + context. Models are getting better all the time; context is now the bottleneck. On large, mission-critical codebases, agents can only solve around 40% of problems — they guess at runtime behavior because source code alone doesn't tell them what actually happened. Undo closes that gap. Undo produces a deterministic recording of program execution. Complete control-flow and dataflow, within and across every module. Coding agents query the recording to reason about dynamic behaviour the way they already reason about static code. The result: fully automated root-cause analysis, with engineers able to see exactly what agent-generated code did and why. Recordings are the antidote to hallucination. Thousands of developers at the world's most demanding software companies, including Nvidia, AWS, Bloomberg and Palo Alto Networks, rely on Undo to solve problems up to 100x faster, release on time, maintain stability at scale, and deliver better customer experiences. Undo is more than a tool. We partner with enterprise engineering teams through concierge onboarding, expert training, and dedicated support to deliver measurable impact within the first six months of deployment.
$1.9M Seed
today
Solius Labs
Unlock the health benefits of the sun in approximately five minutes per week. Solius is the only FDA-cleared over-the-counter UVB light therapy device that analyzes your unique skin tone to deliver a precise, optimal dose of UVB light therapy, stimulating the natural health benefits of the sun with less than 1% of the total UV risk. We are bringing the science of UVB light, on demand and personalized to you, into homes and professional wellness settings. Launching Summer 2026.
$23.0M Series a
today